Liver-derived IGF-I is permissive for ovariectomy-induced trabecular bone loss

Bone

Volumn 38, Issue 1, 2006, Pages 85-92

  Lindberg, M K ^a   Svensson, J ^a   Venken, K ^b   Chavoshi, T ^c   Andersson, N ^a   Moverare Skrtic S ^a   Isaksson, O ^a   Vanderschueren, D ^b   Carlsten, H ^c   Ohlsson, C ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

IGF I; Liver; Trabecular bone

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 7; LIGAND; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MARROW; BONE MARROW CELL; CELL FUNCTION; CELL MATURATION; CELL STIMULATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ESTROGEN DEFICIENCY; FEMALE; FEMUR; FLUORESCENCE ACTIVATED CELL SORTING; LIVER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; OSTEOLYSIS; OVARIECTOMY; PARAMETER; PHENOTYPE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION; THICKNESS; TRABECULAR BONE; WILD TYPE;

ACID PHOSPHATASE; ANIMALS; B-LYMPHOCYTES; BONE DENSITY; CARRIER PROTEINS; FEMALE; FEMUR; FLOW CYTOMETRY; INSULIN-LIKE GROWTH FACTOR I; ISOENZYMES; LIVER; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; OSTEOPOROSIS; OVARIECTOMY; POLYMERASE CHAIN REACTION; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RNA, MESSENGER; T-LYMPHOCYTES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 29344432987     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.07.027     Document Type: Article

References (49)

1. S.L. Abboud, C.R. Bethel, and D.C. Aron Secretion of insulinlike growth factor I and insulinlike growth factor-binding proteins by murine bone marrow stromal cells J. Clin. Invest. 88 1991 470 475
2. P. Ammann, R. Rizzoli, J.P. Bonjour, S. Bourrin, J.M. Meyer, and P. Vassalli Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency J. Clin. Invest. 99 1997 1699 1703
3. S. Cenci, G. Toraldo, M.N. Weitzmann, C. Roggia, Y. Gao, and W.P. Qian Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator Proc. Natl. Acad. Sci. U.S.A. 100 2003 10405 10410
4. S. Cenci, M.N. Weitzmann, C. Roggia, N. Namba, D. Novack, and J. Woodring Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha J. Clin. Invest. 106 2000 1229 1237
5. R. Clark The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function Endocr. Rev. 18 1997 157 179
6. E. Daci, A. Verstuyf, K. Moermans, R. Bouillon, and G. Carmeliet Mice lacking the plasminogen activator inhibitor 1 are protected from trabecular bone loss induced by estrogen deficiency J. Bone Miner. Res. 15 2000 1510 1516
7. F. De Benedetti, M. Massa, P. Pignatti, M. Kelley, C.R. Faltynek, and A. Martini Elevated circulating interleukin-7 levels in patients with systemic juvenile rheumatoid arthritis J. Rheumatol. 22 1995 1581 1585
8. L.A. Feldkamp, L.C. Davis, and J.W. Kress Practical cone-beam algorithm J. Opt. Soc. Am. 1 1984 612 619
9. G.S. Firestein Evolving concepts of rheumatoid arthritis Nature 423 2003 356 361
10. T.J. Fry, and C.L. Mackall Interleukin-7: from bench to clinic Blood 99 2002 3892 3904
11. T. Hildebrand, and P. Ruegsegger Quantification of bone microarchitecture with the structure model index Comput. Methods Biomech. Biomed. Eng. 1 1997 15 23
12. L.C. Hofbauer, and A.E. Heufelder Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology J. Mol. Med. 79 2001 243 253
13. L.C. Hofbauer, D.L. Lacey, C.R. Dunstan, T.C. Spelsberg, B.L. Riggs, and S. Khosla Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells Bone 25 1999 255 259
14. R. Hofmeister, A.R. Khaled, N. Benbernou, E. Rajnavolgyi, K. Muegge, and S.K. Durum Interleukin-7: physiological roles and mechanisms of action Cytokine Growth Factor Rev. 10 1999 41 60
15. M. Kanematsu, T. Sato, H. Takai, K. Watanabe, K. Ikeda, and Y. Yamada Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency J. Bone Miner. Res. 15 2000 1321 1329
16. R.B. Kimble, R. Kitazawa, J.L. Vannice, and R. Pacifici Persistent bone-sparing effect of interleukin-1 receptor antagonist: a hypothesis on the role of IL-1 in ovariectomy-induced bone loss Calcif. Tissue Int. 55 1994 260 265
17. R.B. Kimble, S. Srivastava, F.P. Ross, A. Matayoshi, and R. Pacifici Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production J. Biol. Chem. 271 1996 28890 28897
18. R. Kitazawa, R.B. Kimble, J.L. Vannice, V.T. Kung, and R. Pacifici Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice J. Clin. Invest. 94 1994 406 2397
19. Y.Y. Kong, U. Feige, I. Sarosi, B. Bolon, A. Tafuri, and S. Morony Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand Nature 402 1999 304 309
20. Y.Y. Kong, H. Yoshida, I. Sarosi, H.L. Tan, E. Timms, and C. Capparelli OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis Nature 397 1999 315 323
21. R. Kooijman, M. Willems, C.J. DeHaas, G.T. Rijkers, A.L. Schuurmans, and S.C. Van Buul-Offers Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells Endocrinology 131 1992 2244 2250
22. R.W. Kozak, J.F. Haskell, L.A. Greenstein, M.M. Rechler, T.A. Waldmann, and S.P. Nissley Type I and II insulin-like growth factor receptors on human phytohemagglutinin-activated T lymphocytes Cell Immunol. 109 1987 318 331
23. L. Leistad, M. Ostensen, and A. Faxvaag Detection of cytokine mRNA in human, articular cartilage from patients with rheumatoid arthritis and osteoarthritis by reverse transcriptase-polymerase chain reaction Scand. J. Rheumatol. 27 1998 61 67
24. M.K. Lindberg, Z. Weihua, N. Andersson, S. Moverare, H. Gao, and O. Vidal Estrogen receptor specificity for the effects of estrogen in ovariectomized mice J. Endocrinol. 174 2002 167 178
25. J.A. Lorenzo, A. Naprta, Y. Rao, C. Alander, M. Glaccum, and M. Widmer Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy Endocrinology 139 1998 3022 3025
26. C. Miyaura, Y. Onoe, M. Inada, K. Maki, K. Ikuta, and M. Ito Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency Proc. Natl. Acad. Sci. U.S.A. 94 1997 9360 9365
27. S. Moverare, K. Venken, A.L. Eriksson, N. Andersson, S. Skrtic, and J. Wergedal Differential effects on bone of estrogen receptor alpha and androgen receptor activation in orchidectomized adult male mice Proc. Natl. Acad. Sci. U.S.A. 100 2003 13573 13578
28. T. Nyman, and F. Pekonen The expression of insulin-like growth factors and their binding proteins in normal human lymphocytes Acta Endocrinol. (Copenh) 128 1993 168 172
29. C. Ohlsson, B.A. Bengtsson, O.G. Isaksson, T.T. Andreassen, and M.C. Slootweg Growth hormone and bone Endocr. Rev. 19 1998 55 79
30. A.M. Parfitt, M.K. Drezner, F.H. Glorieux, J.A. Kanis, H. Malluche, and P.J. Meunier Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee J. Bone Miner. Res. 2 1987 595 610
31. V. Poli, R. Balena, E. Fattori, A. Markatos, M. Yamamoto, and H. Tanaka Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion EMBO J. 13 1994 1189 1196
32. Q. Qu, P.L. Harkonen, J. Monkkonen, and H.K. Vaananen Conditioned medium of estrogen-treated osteoblasts inhibits osteoclast maturation and function in vitro Bone 25 1999 211 215
33. D. Rickard, G. Russell, and M. Gowen Oestradiol inhibits the release of tumour necrosis factor but not interleukin 6 from adult human osteoblasts in vitro Osteoporos. Int. 2 1992 94 102
34. B.L. Riggs, S. Khosla, and L.J. Melton III Sex steroids and the construction and conservation of the adult skeleton Endocr. Rev. 23 2002 279 302
35. C. Roggia, Y. Gao, S. Cenci, M.N. Weitzmann, G. Toraldo, and G. Isaia Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo Proc. Natl. Acad. Sci. U.S.A. 98 2001 13960 13965
36. F.P. Ross Interleukin 7 and estrogen-induced bone loss Trends Endocrinol. Metab. 14 2003 147 149
37. T. Sato, T. Shibata, K. Ikeda, and K. Watanabe Generation of bone-resorbing osteoclasts from B220+ cells: its role in accelerated osteoclastogenesis due to estrogen deficiency J. Bone Miner. Res. 16 2001 2215 2221
38. K. Sjogren, J.L. Liu, K. Blad, S. Skrtic, O. Vidal, and V. Wallenius Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice Proc. Natl. Acad. Sci. U.S.A. 96 1999 7088 7092
39. K. Sjogren, M. Sheng, S. Moverare, J.L. Liu, K. Wallenius, and J. Tornell Effects of liver-derived insulin-like growth factor I on bone metabolism in mice J. Bone Miner. Res. 17 2002 1977 1987
40. C.A. Stuart, R.T. Meehan, L.S. Neale, N.M. Cintron, and R.W. Furlanetto Insulin-like growth factor-I binds selectively to human peripheral blood monocytes and B-lymphocytes J. Clin. Endocrinol. Metab. 72 1991 1117 1122
41. V.F. Tapson, M. Boni-Schnetzler, P.F. Pilch, D.M. Center, and J.S. Berman Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro J. Clin. Invest. 82 1988 950 957
42. G. Toraldo, C. Roggia, W.P. Qian, R. Pacifici, and M.N. Weitzmann IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells Proc. Natl. Acad. Sci. U.S.A. 100 2003 125 130
43. J.H. Waarsing, J.S. Day, and H. Weinans An improved segmentation method for in vivo micro-CT imaging J. Bone Miner. Res. 2004 (Oct 19) 1640 1650
44. H.O. Valenzona, R. Pointer, R. Ceredig, and D.G. Osmond Prelymphomatous B cell hyperplasia in the bone marrow of interleukin-7 transgenic mice: precursor B cell dynamics, microenvironmental organization and osteolysis Exp. Hematol. 24 1996 1521 1529
45. D. Vanderschueren, L. Vandenput, S. Boonen, M.K. Lindberg, R. Bouillon, and C. Ohlsson Androgens and bone Endocr. Rev. 25 2004 389 425
46. M.N. Weitzmann, S. Cenci, L. Rifas, C. Brown, and R. Pacifici Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines Blood 96 2000 1873 1878
47. M.N. Weitzmann, C. Roggia, G. Toraldo, L. Weitzmann, and R. Pacifici Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency J. Clin. Invest. 110 2002 1643 1650
48. S.H. Windahl, O. Vidal, G. Andersson, J.A. Gustafsson, and C. Ohlsson Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice J. Clin. Invest. 104 1999 895 901
49. S. Yakar, C.J. Rosen, W.G. Beamer, C.L. Ackert-Bicknell, Y. Wu, and J.L. Liu Circulating levels of IGF-1 directly regulate bone growth and density J. Clin. Invest. 110 2002 771 781